Shoreline Biosciences
Los Angeles, CA
Shoreline Biosciences is a biomedical company intended to establish immunotherapies for seriously ill patients. Its proprietary cell therapy technology platform is based on deep expertise in iPSC differentiation methods and genetic programming of the IL-15/CISH pathway for enhanced metabolic fitness and persistence of the engineered NK Cells to improve anti-cancer activity. The company was founded in 2020 and is headquartered in La Jolla, CA, USA.
shorelinebio.comCompany Details
Founded
- 2020
Employees
- Between 50 - 100 employees
Raised
- $186,000,000
Headquarters Location
- Los Angeles, CA
Public
- No
Acquired
- No
CEO
- Kleanthis G. Xanthopoulos
Founders
- Steven H. HoltzmanDan S KaufmanWilliam SandbornKleanthis G. Xanthopoulos
Company Collections
These are collections Shoreline Biosciences is a part of. Click on the collection name to view similar companies.